Office of the Director, National Institutes of Health; Notice of Meeting, 9522 [2021-03018]

Download as PDF 9522 Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices Collaborative Research Opportunity: The National Institute of Allergy and Infectious Diseases is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate or commercialize this invention. Interested parties should have the ability to manufacture viruses under cGMP, suitable for Phase 1–2 testing by NIAID. Capabilities for further clinical development, and experience with Phase 3 testing, licensure, and rollout are preferred. For collaboration opportunities, please contact Chris Kornak at chris.kornak@nih.gov. Dated: January 29, 2021. Surekha Vathyam, Deputy Director, Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases. [FR Doc. 2021–03044 Filed 2–12–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting khammond on DSKJM1Z7X2PROD with NOTICES Notice is hereby given of a meeting of the HEAL (Helping to End Addiction Long-term) Multi-Disciplinary Working Group The meeting will be open to the public as indicated below via NIH Videocast. Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The program documents and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the program documents, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: HEAL MultiDisciplinary Working Group Meeting. Date: March 2–3, 2021. Open: March 02, 2021, 11:00 a.m. to 12:20 p.m. Closed: March 02, 2021, 12:20 p.m. to 4:30 p.m. Open: March 03, 2021, 10:30 a.m. to 11:05 a.m. Closed: March 03, 2021, 11:05 a.m. to 2:45 p.m. VerDate Sep<11>2014 17:04 Feb 12, 2021 Jkt 253001 Agenda: Provide an update on Helping to End Addiction Long-Term (HEAL) Initiative projects and obtain expertise from MDWG relevant to the NIH HEAL Initiative and to specific HEAL projects. Videocast: The open portion of the meeting will be live webcast at: https:// videocast.nih.gov/. Place: National Institutes of Health Building 1, Wilson Hall, 1 Center Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Rebecca G Baker, Ph.D., Office of the Director, National Institutes of Health, 1 Center Drive, Room 103A, Bethesda, MD 20892, (301) 402–1994, Rebecca.baker@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Office of the Director for the NIH HEAL Initiative home page: https://heal.nih.gov/news where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: February 9, 2021. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–03018 Filed 2–12–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting AGENCY: National Institutes of Health, HHS. ACTION: Notice. The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on March 3, 2021. The topic for this meeting will be ‘‘COVID–19 and Diabetes.’’ The meeting is open to the public. DATES: The meeting will be held on March 3, 2021 from 12 noon to 4:00 p.m. EST. ADDRESSES: The meeting will be held via the online video conferencing— Zoom. For details, and to register, please contact dmicc@mail.nih.gov. FOR FURTHER INFORMATION CONTACT: For further information concerning this meeting, including a draft agenda, see the DMICC website, www.diabetescommittee.gov, or contact SUMMARY: PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Dr. B. Tibor Roberts, Executive Secretary of the Diabetes Mellitus Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 31A, Room 9A19, MSC 2560, Bethesda, MD 20892– 2560, telephone: 301–496–6623; FAX: 301–480–6741; email: dmicc@ mail.nih.gov. In accordance with 42 U.S. Code 285c–3, the DMICC, chaired by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising members of the Department of Health and Human Services and other federal agencies that support diabetes-related activities, facilitates cooperation, communication, and collaboration on diabetes among government entities. DMICC meetings, held several times a year, provide an opportunity for Committee members to learn about and discuss current and future diabetes programs in DMICC member organizations and to identify opportunities for collaboration. The March 3, 2021 DMICC meeting will focus on ‘‘COVID–19 and Diabetes.’’ Any member of the public interested in presenting oral comments to the Committee should notify the contact person listed on this notice at least 5 days in advance of the meeting. Interested individuals and representatives or organizations should submit a letter of intent, a brief description of the organization represented, and a written copy of their oral presentation in advance of the meeting. Only one representative of an organization will be allowed to present; oral comments and presentations will be limited to a maximum of 5 minutes. Printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the Committee by forwarding their statement to the contact person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Because of time constraints for the meeting, oral comments will be allowed on a first-come, first-serve basis. Members of the public who would like to receive email notification about future DMICC meetings should register for the listserv available on the DMICC website, www.diabetescommittee.gov. SUPPLEMENTARY INFORMATION: E:\FR\FM\16FEN1.SGM 16FEN1

Agencies

[Federal Register Volume 86, Number 29 (Tuesday, February 16, 2021)]
[Notices]
[Page 9522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03018]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Notice is hereby given of a meeting of the HEAL (Helping to End 
Addiction Long-term) Multi-Disciplinary Working Group
    The meeting will be open to the public as indicated below via NIH 
Videocast. Individuals who need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The program documents and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the program documents, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: HEAL Multi-Disciplinary Working Group 
Meeting.
    Date: March 2-3, 2021.
    Open: March 02, 2021, 11:00 a.m. to 12:20 p.m.
    Closed: March 02, 2021, 12:20 p.m. to 4:30 p.m.
    Open: March 03, 2021, 10:30 a.m. to 11:05 a.m.
    Closed: March 03, 2021, 11:05 a.m. to 2:45 p.m.
    Agenda: Provide an update on Helping to End Addiction Long-Term 
(HEAL) Initiative projects and obtain expertise from MDWG relevant 
to the NIH HEAL Initiative and to specific HEAL projects.
    Videocast: The open portion of the meeting will be live webcast 
at: https://videocast.nih.gov/.
    Place: National Institutes of Health Building 1, Wilson Hall, 1 
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Rebecca G Baker, Ph.D., Office of the Director, 
National Institutes of Health, 1 Center Drive, Room 103A, Bethesda, 
MD 20892, (301) 402-1994, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Office of the Director for 
the NIH HEAL Initiative home page: https://heal.nih.gov/news where 
an agenda and any additional information for the meeting will be 
posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: February 9, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-03018 Filed 2-12-21; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.